DexCom Shares Jump After ADA Presentation, Nutrisense Deal and Stelo App Relaunch
DexCom shares rose sharply in morning trading after the company concluded a major presence at the American Diabetes Association’s Scientific Sessions, unveiled new clinical results from the CONNECT study, announced an agreement to acquire Nutrisense, and rolled out an early-access version of a redesigned Stelo app aimed at people with Type 2 diabet…